Pharmaceutical Technology ePT Weekly: Having trouble viewing this e-mail? Click here.

News Industry Briefs Webcasts Events About Us

Webcast: Optimizing Quality by Design in Bulk Powders and Solid Dosage Sponsored by Hovione Webcast: Trends in Safe Handling of Potent Compounds in Pharmaceutical Manufacturing Processes Sponsored by Patheon More Webcasts ExcipientFest Americas 2013 April 30–May 1, 2013 Baltimore, MD, USA Advertisement: Pharmaceutical Technology Drug Delivery Guides A three-volume set of drug delivery system handbooks. A compilation of articles on methods and processes of manufacturing and administering pharmaceutical compounds to achieve therapeutic effects.Ttopics include the development of controlled-release formulations and reformulating injectable drugs for oral delivery. Click here

April 25, 2013 PharmTech.com PRINT SUBSCRIBE DIGITAL SUBSCRIBE Scientist Jailed for Falsifying Research Data A scientist working for Aptuit has been jailed three months for falsifying preclinical safety data on experimental anticancer drugs due for clinical evaluation. FDA Will Not Approve Generics to Original OxyContin The FDA approved updated labeling for Purdue Pharma L.P.’s reformulated OxyContin tablets, but also determined that it will not approve generic versions of the original OxyContin. Sanofi and PATH Launch Semisynthetic Artemisinin Production New manufacturing route improves availability of ingredient for malaria treatment. Allergan Receives Complete Response Letter for Levadex New Drug Application Allergan has addressed FDA’s concerns with canister filling and has received draft labeling from FDA. Autoinjector Enables Delivery of High-Viscosity Formulations Oval Medical Technologies reported that a variety of highly viscous solutions have been successfully delivered through a 25-gauge thin-wall needle, in less than 7 seconds, using its innovative autoinjector. Advertisement: Tablet manufacturing problems? By partnering with Long Island University, Natoli Engineering has developed the Natoli Engineering Institute for Industrial Pharmacy Development and Research. Our mission is to provide customers with unique product solutions to their specific issues based on a combination of science and experience. Learn More! Cipla Launches First Biosimilar of Etanercept in India Cipla has launched the first biosimilar of etanercept in India for the treatment of rheumatoid disorders. The product will be marketed under the brand name Etacept. Advertisement: A Pragmatic Application of QbD: Turning Theory into Tangible Success Live Webcast: Thursday, May 2, 2013 at 11:00 am EDT. Register Free at www.pharmtech.com/pragmatic Positive Phase III Results for Lilly's Dulaglutide Eli Lilly has announced positive top-line results for two of its Phase III trials, which evaluated dulaglutide as a once-weekly treatment in patients with type 2 diabetes. Advertisement: Trends in safe handling of potent compounds in pharmaceutical manufacturing processes Live Webcast: Wednesday, May 15, 2013 at 11:00 AM EDT. Register Free at www.pharmtech.com/trends FDA Releases Guidance on Non-Penicillin Beta-Lactam Drugs FDA has released Guidance for Industry: Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination. Merck Opens New Manufacturing Facility in China The facility in Hangzhou will package Merck medicines for China and the Asia-Pacific region. Metrics Inc. Offers Taste Masking for Tablets Metrics Inc. offers Cleantaste technology, which can improve the taste and mouth-feel of drugs, the company reports. Entegris Acquires Jetalon Solutions Unique technology expands Entegris’ fluid-sensing and control offering. Advertisement: Cleaning Validation: Science, Risk, and Novel Approaches to Testing Live Webcast: Tuesday, June 4, 2013 at 11:00 am EDT. Register Free at www.pharmtech.com/testing

At INTERPHEX, which sessions will you be most interested in attending? Design Space 72%   Highly-potent products 7%       Continuous manufacturing 6%       Vaccine manufacturing 7%       None of the above. I want to see new equipment 8% This week we would like to know... What has been the most significant benefit of applying quality-by-design (QbD) principles? Contact Us Click here to contact editorial. Click here to contact sales.

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |